Susan P. Sambol

6.3k total citations · 2 hit papers
51 papers, 5.0k citations indexed

About

Susan P. Sambol is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Susan P. Sambol has authored 51 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 33 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Susan P. Sambol's work include Clostridium difficile and Clostridium perfringens research (47 papers), Microscopic Colitis (30 papers) and Viral gastroenteritis research and epidemiology (19 papers). Susan P. Sambol is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (47 papers), Microscopic Colitis (30 papers) and Viral gastroenteritis research and epidemiology (19 papers). Susan P. Sambol collaborates with scholars based in United States, United Kingdom and Australia. Susan P. Sambol's co-authors include Stuart Johnson, Dale N. Gerding, George Killgore, L. Clifford McDonald, Angela Thompson, Robert C. Owens, Sophia V. Kazakova, Michelle M. Merrigan, Gayatri Vedantam and Jennifer R. O’Connor and has published in prestigious journals such as Nature, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

Susan P. Sambol

51 papers receiving 4.8k citations

Hit Papers

An Epidemic, Toxin Gene–Variant Strain of Clostridium dif... 2005 2026 2012 2019 2005 2009 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
    2005 1.6k citations L. Clifford McDonald, George Killgore et al. profile →
  2. Toxin B is essential for virulence of Clostridium difficile
    2009 589 citations Jennifer R. O’Connor, Susan P. Sambol et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan P. Sambol United States 32 4.6k 3.0k 1.0k 684 494 51 5.0k
Angela Thompson United States 19 4.1k 0.9× 2.6k 0.9× 743 0.7× 668 1.0× 447 0.9× 20 4.5k
Martijn P. Bauer Netherlands 22 3.4k 0.7× 2.4k 0.8× 728 0.7× 615 0.9× 480 1.0× 39 3.7k
Anne–Marie Bourgault Canada 26 2.9k 0.6× 2.2k 0.8× 645 0.6× 589 0.9× 360 0.7× 60 3.9k
Paola Mastrantonio Italy 31 2.1k 0.5× 1.5k 0.5× 407 0.4× 211 0.3× 492 1.0× 113 3.1k
Sophia V. Kazakova United States 7 2.1k 0.5× 1.3k 0.4× 397 0.4× 349 0.5× 270 0.5× 21 2.3k
Baldwin Toye Canada 29 1.3k 0.3× 1.4k 0.5× 391 0.4× 371 0.5× 307 0.6× 70 3.1k
V. Lalande France 26 1.6k 0.3× 1.2k 0.4× 339 0.3× 191 0.3× 278 0.6× 66 2.0k
Pierre René Canada 14 1.7k 0.4× 1.2k 0.4× 355 0.3× 319 0.5× 133 0.3× 24 2.0k
T.-W. Chang United States 14 1.8k 0.4× 942 0.3× 272 0.3× 241 0.4× 319 0.6× 30 2.2k
Jane W. Marsh United States 30 1.3k 0.3× 1.2k 0.4× 173 0.2× 259 0.4× 418 0.8× 66 2.8k

Countries citing papers authored by Susan P. Sambol

Since Specialization
Citations

This map shows the geographic impact of Susan P. Sambol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan P. Sambol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan P. Sambol more than expected).

Fields of papers citing papers by Susan P. Sambol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan P. Sambol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan P. Sambol. The network helps show where Susan P. Sambol may publish in the future.

Co-authorship network of co-authors of Susan P. Sambol

This figure shows the co-authorship network connecting the top 25 collaborators of Susan P. Sambol. A scholar is included among the top collaborators of Susan P. Sambol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan P. Sambol. Susan P. Sambol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sambol, Susan P., et al.. (2023). Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin. Microbiology Spectrum. 11(2). e0051723–e0051723. 9 indexed citations
2.
Sambol, Susan P., Stuart Johnson, Adam Cheknis, & Dale N. Gerding. (2022). Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments. PLoS ONE. 17(6). e0270119–e0270119. 3 indexed citations
3.
Skinner, Andrew M, Michelle M. Merrigan, Kevin J. O’Leary, et al.. (2020). The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile. Journal of Clinical Medicine. 10(1). 96–96. 11 indexed citations
4.
Gerding, Dale N., Susan P. Sambol, & Stuart Johnson. (2018). Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside. Frontiers in Microbiology. 9. 1700–1700. 37 indexed citations
5.
Donskey, Curtis J., Venkata Sunkesula, Nimalie D. Stone, et al.. (2018). Transmission ofClostridium difficilefrom asymptomatically colonized or infected long-term care facility residents. Infection Control and Hospital Epidemiology. 39(8). 909–916. 34 indexed citations
6.
Cheknis, Adam, Stuart Johnson, Laurent Chesnel, et al.. (2018). Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015. Anaerobe. 53. 38–42. 27 indexed citations
7.
Gerding, Dale N., D. W. Hecht, Thomas Louie, et al.. (2015). Susceptibility ofClostridium difficileisolates from a Phase 2 clinical trial of cadazolid and vancomycin inC. difficileinfection. Journal of Antimicrobial Chemotherapy. 71(1). 213–219. 27 indexed citations
8.
Edmonds, Sarah, Robert A. Gerber, David R. Macinga, et al.. (2013). Effectiveness of Hand Hygiene for Removal of Clostridium difficile Spores from Hands. Infection Control and Hospital Epidemiology. 34(3). 302–305. 44 indexed citations
9.
Nagaro, Kristin, et al.. (2013). Nontoxigenic Clostridium difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic BI/NAP1/027 C. difficile. Antimicrobial Agents and Chemotherapy. 57(11). 5266–5270. 61 indexed citations
10.
Donskey, Curtis J., Venkata Sunkesula, Annette Jencson, et al.. (2013). Utility of a Commercial PCR Assay and a Clinical Prediction Rule for Detection of Toxigenic Clostridium difficile in Asymptomatic Carriers. Journal of Clinical Microbiology. 52(1). 315–318. 20 indexed citations
11.
Figueroa, Isabel, Stuart Johnson, Susan P. Sambol, et al.. (2012). Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin. Clinical Infectious Diseases. 55(suppl 2). S104–S109. 105 indexed citations
12.
Sambol, Susan P., Adam Cheknis, Kristin Nagaro, et al.. (2012). Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain. Clinical Infectious Diseases. 55(3). 351–357. 151 indexed citations
13.
Price, James, Elizabeth Cheek, Marc Cubbon, et al.. (2009). Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis. Clinical Microbiology and Infection. 16(8). 1297–1302. 51 indexed citations
14.
O’Connor, Jennifer R., Minerva Galang, Susan P. Sambol, et al.. (2008). Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile. Antimicrobial Agents and Chemotherapy. 52(8). 2813–2817. 162 indexed citations
15.
Stare, Barbara Gerič, Robert J. Carman, Maja Rupnik, et al.. (2006). Binary Toxin–Producing, Large Clostridial Toxin–NegativeClostridium difficileStrains Are Enterotoxic but Do Not Cause Disease in Hamsters. The Journal of Infectious Diseases. 193(8). 1143–1150. 157 indexed citations
16.
Merrigan, Michelle M., Susan P. Sambol, Stuart Johnson, & Dale N. Gerding. (2003). Prevention of FatalClostridium difficile–Associated Disease during Continuous Administration of Clindamycin in Hamsters. The Journal of Infectious Diseases. 188(12). 1922–1927. 44 indexed citations
17.
Gerding, Dale N., Susan P. Sambol, Jean M. Pottinger, et al.. (2002). Predominance of a Single Restriction Endonuclease Analysis Group with Intrahospital Subgroup Diversity AmongClostridium difficileIsolates at Two Chicago Hospitals. Infection Control and Hospital Epidemiology. 23(11). 648–652. 8 indexed citations
18.
Sambol, Susan P., Michelle M. Merrigan, David M. Lyerly, Dale N. Gerding, & Stuart Johnson. (2000). Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical Disease. Infection and Immunity. 68(10). 5480–5487. 63 indexed citations
19.
Samore, Matthew H., George Killgore, Stuart Johnson, et al.. (1997). Multicenter Typing Comparison of Sporadic and OutbreakClostridium difficileIsolates from Geographically Diverse Hospitals. The Journal of Infectious Diseases. 176(5). 1233–1238. 52 indexed citations
20.
Rowley, Anne H., et al.. (1991). RAPID DETECTION OF CYTOMEGALOVIRUS DNA AND RNA IN BLOOD OF RENAL TRANSPLANT PATIENTS BY IN VITRO ENZYMATIC AMPLIFICATION. Transplantation. 51(5). 1028–1032. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Thompson Breakdown of academic impact, for papers by Martijn P. Bauer Breakdown of academic impact, for papers by Anne–Marie Bourgault Breakdown of academic impact, for papers by Paola Mastrantonio Breakdown of academic impact, for papers by Sophia V. Kazakova Breakdown of academic impact, for papers by Baldwin Toye Breakdown of academic impact, for papers by V. Lalande Breakdown of academic impact, for papers by Pierre René Breakdown of academic impact, for papers by T.-W. Chang Breakdown of academic impact, for papers by Jane W. Marsh
Rankless by CCL
2026